Showing results (661-670 of 1,098) with videos related to

Sort By:
Pageof 110
The Journal of Clinical Investigation|April 3, 2008
New challenges in studying nutrition-disease interactions in the developing worldAndrew M Prentice, M Eric Gershwin, Ulrich E Schaible, et al.
The Journal of Biological Chemistry|November 25, 1977
In vitro translation of avian vitellogenin messenger RNAJ I Gordon, R G Deeley, A T Burns, et al.
The Journal of Experimental Medicine|December 17, 2009
Host-dependent Lewis (Le) antigen expression in Helicobacter pylori cells recovered from Leb-transgenic miceMary Ann Pohl, Judith Romero-Gallo, Janaki L Guruge, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Beyond Chemotherapy: Checkpoint Inhibition and Cell-Based Therapy in Non-Hodgkin LymphomaPaolo Strati, Shabnum Patel, Loretta Nastoupil, et al.
The Journal of Biological Chemistry|March 25, 1985
Human liver fatty acid binding protein. Isolation of a full length cDNA and comparative sequence analyses of orthologous and paralogous proteinsJ B Lowe, M S Boguski, D A Sweetser, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2015
Analysis of gene-environment interactions in postnatal development of the mammalian intestineSeth Rakoff-Nahoum, Yong Kong, Steven H Kleinstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2010
Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculataShuo Yang, Andrew M Evens, Sheila Prachand, et al.
Oncotarget|February 1, 2018
GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agentsReem Karmali, Vineela Chukkapalli, Leo I Gordon, et al.
Leukemia & Lymphoma|October 30, 2004
A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)Chadi Nabhan, David Patton, Leo I Gordon, et al.
The Journal of Biological Chemistry|October 15, 1989
Nuclear magnetic resonance studies of 6-fluorotryptophan-substituted rat cellular retinol-binding protein II produced in Escherichia coli. Analysis of the apoprotein and the holoprotein containing bound all-trans-retinol and all-trans-retinalE Li, S J Quian, L Nader, et al.
Pageof 110